Adult T-cell lymphoma/leukaemia recurrent

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
4 Unique IMPs
0 Commercial trials
Drug classes (ATC)
H Endocrinology (ATC H) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Corticosteroid 1 substance
Topoisomerase II inhibitor 1 substance
Alkylating agent 1 substance
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Fondazione IRCCS Istituto Nazionale Dei Tumori Academic
    DEXAMETHASONE PHOSPHATE; ETOPOSIDE; IFOSFAMIDE; SELINEXOR
    2024-513295-18-00 1 country 2022 n=30
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Fondazione IRCCS Istituto Nazionale Dei Tumori Academic 1 Phase II 0
New trials by year
2022
1
← All indication landscapes